ACP-105
A SARM used in muscle growth research.
Overview
ACP-105 is a nonsteroidal SARM crossing the blood-brain barrier, promoting muscle growth, bone density, and cognition with minimal androgenic effects. It reduces anxiety and supports recovery, ideal for dementia and performance enhancement research.
Synonyms: ACP105; Benzonitrile,2-chloro-4-[(3-endo)-3-hydroxy-3-methyl-8-azabicyclo[3.2.1]oct-8-yl]-3-methyl-; PharmaceuticalGradeACP-105; HotSellingACP105; PharmaceuticalChemicalACP105; 2-Chloro-4-[(1R,5R)-3-hydroxy-3-methyl-8-azabicyclo[3.2.1]octan-8-yl]-3-methylbenzonitrile
EINECS: 200-510-5
Product Categories: Export SARM series; pharmaceutical raw materials; export raw materials; inventory; SARM series
Mol File: 899821-23-9.mol
Physicochemical Properties
Melting point: 160°C
Boiling point: 479.8±45.0°C(Predicted)
Density: 1.28±0.1g/cm3(Predicted)
Storage temp.: Refrigerator
Solubility: Chloroform (Slightly), Ethyl Acetate (Slightly), Methanol (Slightly)
Form: Solid
Color: Off-White to Pale Beige
MSDS Information
Experimental Data
1.Cell Experiment
Solubility in DMSO: ≥ 103 mg/mL (354.21 mM; Hygroscopic DMSO significantly affects the solubility of the product, please use freshly opened DMSO)
* "≥" means soluble, but saturation unknown.
Preparing Stock Solutions:
Please choose a suitable solvent to prepare the stock solution based on the product's solubility in different solvents. Once the solution is prepared, aliquot and store it to avoid product degradation caused by repeated freeze-thaw cycles.
Storage conditions and shelf life of the stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, use within 2 years; when stored at -20°C, use within 1 year.
Pharmacodynamics
Mechanism Of Action
Similar Products
AC-262536
Therapy
: Musculoskeletal diseases
Target
:
CAS
: 870888-46-3
MF
: C18H18N2O
MW
: 278.36
AC-262,356
Therapy
: Musculoskeletal diseases
Target
:
CAS
: 871032-12-1
MF
: C18H18N2O
MW
: 278.36
PF-06260414
Therapy
: Musculoskeletal diseases
Target
: Opioid receptors
CAS
: 1612755-71-1
MF
: C14H14N4O2S
MW
: 302.35
GSK-2881078
Therapy
: Musculoskeletal diseases
Target
: AR
CAS
: 1539314-06-1
MF
: C14H13F3N2O2S
MW
: 330.33